Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GB2L
|
|||
| Former ID |
DIB016022
|
|||
| Drug Name |
SNN-0031
|
|||
| Synonyms |
Platelet derived growth factor (parkinson's disease), NeuroNova; PDGF-BB (parkinson's disease), NeuroNova
Click to Show/Hide
|
|||
| Indication | Brain injury [ICD-11: NA07.Z] | Phase 1/2 | [1] | |
| Company |
NeuroNova AB
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02408562) Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD. U.S. National Institutes of Health. | |||
| REF 2 | Company report (Neuronova) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.